Results from a trial of spinal cord stimulation carried out in Ontario, Canada highlights its potential for improving walking in Parkinson's.

Researchers have identified small molecules secreted by the skin that are maybe responsible for a unique scent in people with Parkinson's.

Research shows that deep brain stimulation may help boost energy levels in Parkinson’s brain cells by increasing the size of mitochondria.

A potential drug for dyskinesia has reached an important milestone and can now go forward into clinical trials.

The pioneering GDNF clinical trials programme delivered an experimental treatment directly to the brain. The trial results offer hope that it may be possible to restore the cells damaged in Parkinson’s.

Parkinson's UK is 1 of 24 members of the Association of Medical Research Charities that have worked in collaboration to develop and launch a new open publication platform – AMRC Open Research.

Researchers at King’s College London are starting a world-first clinical trial to test if a probiotic drink could help with motor and non-motor symptoms of Parkinson's.

The groundbreaking clinical trial of GDNF, a potential treatment for Parkinson's, is now complete. Analysis of the results is now well underway and is expected to be published in February 2019.

Parkinson's UK announces partnership with the Insight Into Parkinson's summit 2019.

A clinical trial has produced further evidence that there is no benefit of delaying levodopa therapy.